The landscape for UK R&D SMEs post-COVIDBig pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of Share XThe landscape for UK R&D SMEs post-COVIDhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-2021/the-landscape-for-uk-rd-smes-post-covid/
The Alderley Park Discovery Podcast: The journey to accessing science funding and investmentEpisode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting Share XThe Alderley Park Discovery Podcast: The journey to accessing science funding and investmenthttps://pharmaphorum.com/podcast/life-science-funding-investment-alderley-park/
The Alderley Park Discovery Podcast: Life science skills, staffing and supportEpisode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with Share XThe Alderley Park Discovery Podcast: Life science skills, staffing and supporthttps://pharmaphorum.com/podcast/alderley-park-life-science-skills-staffing/
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse LabAlderley Park’s Mereside campus is at the forefront of the UK’s COVID-19 testing plans, playing a key role Share XThe Alderley Park Discovery Podcast: COVID testing and the Lighthouse Labhttps://pharmaphorum.com/podcast/alderley-park-discovery-podcast-lighthouse-lab/
Making it as an oncology biotech in the UKWe speak to R&D experts to find out how oncology biotechs can get the support they need to Share XMaking it as an oncology biotech in the UKhttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/alderley-park-oncology-biotech-uk/
